These findings collectively suggest that SIRT2 deficiency accelerates NAFLD-NASH progression by causing more severe oxidative stress injury and mitochondrial dysfunction in the liver. This evidence concerns the gene SIRT2 and metabolic dysfunction-associated steatotic liver disease.